- Home
- CLST vs FGEN Comparison
CLST vs FGEN Comparison
Compare CLST & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- FGEN
- Stock Information
- Founded
- CLST 1922
- FGEN 1993
- Country
- CLST United States
- FGEN United States
- Employees
- CLST N/A
- FGEN N/A
- Industry
- CLST
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- FGEN Health Care
- Exchange
- CLST Nasdaq
- FGEN Nasdaq
- Market Cap
- CLST 54.6M
- FGEN 45.0M
- IPO Year
- CLST N/A
- FGEN 2014
- Fundamental
- Price
- CLST $13.30
- FGEN $10.38
- Analyst Decision
- CLST
- FGEN Strong Buy
- Analyst Count
- CLST 0
- FGEN 2
- Target Price
- CLST N/A
- FGEN $146.50
- AVG Volume (30 Days)
- CLST 4.8K
- FGEN 29.2K
- Earning Date
- CLST 10-24-2025
- FGEN 11-11-2025
- Dividend Yield
- CLST N/A
- FGEN N/A
- EPS Growth
- CLST N/A
- FGEN N/A
- EPS
- CLST 0.58
- FGEN N/A
- Revenue
- CLST $11,354,000.00
- FGEN $7,346,000.00
- Revenue This Year
- CLST N/A
- FGEN N/A
- Revenue Next Year
- CLST N/A
- FGEN N/A
- P/E Ratio
- CLST $23.01
- FGEN N/A
- Revenue Growth
- CLST 164.54
- FGEN N/A
- 52 Week Low
- CLST $10.67
- FGEN $4.50
- 52 Week High
- CLST $14.23
- FGEN $21.94
- Technical
- Relative Strength Index (RSI)
- CLST 64.78
- FGEN 39.54
- Support Level
- CLST $13.20
- FGEN $10.29
- Resistance Level
- CLST $13.37
- FGEN $11.24
- Average True Range (ATR)
- CLST 0.05
- FGEN 0.61
- MACD
- CLST -0.01
- FGEN -0.18
- Stochastic Oscillator
- CLST 72.12
- FGEN 5.07
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.